3rd Annual World Preclinical Congress
Date: November 27-30, 2018
Location: Lisbon - PortugalGENFIT will attend the "NASH and Fibrosis: Translational Research and Strategies" Conference, part of the 3rd Annual World Preclinical Congress. On this occasion, Robert Walczak, PhD, Head of Research, will hold a presentation on "Development of Dual PPAR Agonist and IVD in NASH" on November 28, 8:30 (UTC+1). More information is available on the event's website.
Save this event:Export Ical